Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Tislelizumab can cause cutaneous lupus erythematosus.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Atopy and altered T cell functions contribute to Alopecia Areata.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Researchers found a new mutation in the LIPH gene of a woman with a rare hair condition.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Ezh2 controls skin development by balancing signals for dermal and epidermal growth.

Integrin-linked kinase is crucial for melanoblasts to properly colonize the skin.

Ubiquitination of the insulin receptor regulates collagen secretion in human skin.

Enhancing Tregs can protect against alopecia areata.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Overexpressing 14-3-3σ in mice skin reduces cell growth and hair density.

ILK is essential for proper hair follicle development and structure.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Follistatin helps hair growth and cycling, while activin prevents it.